Area of research
Oncology · Epidemiology
Research interest
Research interests include Cervical Cancer and HPV Research, Global Cancer Incidence and Screening, Colorectal Cancer Screening and Detection, and Endometrial and Cervical Cancer Treatments.
The National Health Service-Galleri multicancer screening trial: explanation and justification of unique and important design issues.
Implementation of the NHS England Lung Cancer Screening Programme over 5 years.
<i>Helicobacter pylori</i> Screen-and-Treat Programs for Gastric Cancer Prevention — IARC Working Group Report
Evaluating the basis for use of advanced stage as a surrogate endpoint for cancer mortality in screening trials: a simulation study of meta-correlation and an alternative framework.
From promise to proof: reference sets for validation of multicancer early detection.
Improved stage-specific survival in screen-detected breast cancer in Denmark: a cohort study.
Self-Supervised Text-Vision Alignment for Automated Brain MRI Abnormality Detection: A Multicenter Study (ALIGN Study).
Genetic prediction of long-term effects of aromatase inhibition on cancer and non-neoplastic disease risk
Promises and pitfalls of multi-cancer early detection using liquid biopsy tests
Biomarker risk stratification with capsule sponge in the surveillance of Barrett's oesophagus: prospective evaluation of UK real-world implementation
Promises and pitfalls of multi-cancer early detection using liquid biopsy tests.
More efficient, smaller multicancer screening trials.
Association between HPV vaccination and cervical screening policy changes and cervical cancer incidence and grade-3 cervical intraepithelial neoplasia incidence in England, 2006-2020: a population-based trends analysis.
Study protocol: multi-centre, randomised controlled clinical trial exploring stromal targeting in locally advanced pancreatic cancer; STARPAC2.
Estimands for Clinical Effectiveness of Risk-Reducing Early Salpingectomy in Women With High Risk of Ovarian Cancer
NHS-Galleri trial: Enriched enrolment approaches and sociodemographic characteristics of enrolled participants.
Urine human papillomavirus testing for cervical screening in a UK general screening population: a diagnostic test accuracy study
Assessment of the impact of multi-cancer early detection test screening intervals on late-stage cancer at diagnosis and mortality using a state-transition model.
Protocol for a randomised phase 3 trial evaluating the role of Finasteride in Active Surveillance for men with low and intermediate-risk prostate cancer: the FINESSE Study.
Late-Stage Outcomes as Surrogates for Mortality in Cancer Screening Trials: A Systematic Review and Meta-analysis.
Impact of mode of offer of self-sampling to people overdue cervical screening on screening participation: a randomised controlled trial.
Impact of hospital-specific domain adaptation on BERT-based models to classify neuroradiology reports.
Urine High Risk Human Papillomavirus Testing As An Alternative Cervical Screening Strategy: The ACES Studies
Figure S4 from Late-Stage Outcomes as Surrogates for Mortality in Cancer Screening Trials: A Systematic Review and Meta-analysis
Figure S2 from Late-Stage Outcomes as Surrogates for Mortality in Cancer Screening Trials: A Systematic Review and Meta-analysis
Supplementary Methods and Tables from Late-Stage Outcomes as Surrogates for Mortality in Cancer Screening Trials: A Systematic Review and Meta-analysis
Figure 4 from Late-Stage Outcomes as Surrogates for Mortality in Cancer Screening Trials: A Systematic Review and Meta-analysis
Figure 5 from Late-Stage Outcomes as Surrogates for Mortality in Cancer Screening Trials: A Systematic Review and Meta-analysis
Figure S3 from Late-Stage Outcomes as Surrogates for Mortality in Cancer Screening Trials: A Systematic Review and Meta-analysis
Figure 3 from Late-Stage Outcomes as Surrogates for Mortality in Cancer Screening Trials: A Systematic Review and Meta-analysis